Ocugen, Inc.
US ˙ NasdaqCM ˙ US67577C1053

Introduction

This page provides a comprehensive analysis of the known insider trading history of Junge Zhang. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Junge Zhang has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:OCGN / Ocugen, Inc. Director 1,077,182
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Junge Zhang. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases OCGN / Ocugen, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in OCGN / Ocugen, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2023-06-14 OCGN Zhang Junge 200,278 0.4993 200,278 0.4993 99,999 337 1.9800 296,552 296.56
2019-12-04 OCGN Zhang Junge 220,000 0.4400 220,000 0.4400 96,800
2019-11-25 OCGN Zhang Junge 115,000 0.2700 115,000 0.2700 31,050
2019-11-22 OCGN Zhang Junge 80,000 0.2800 80,000 0.2800 22,400
2019-11-18 OCGN Zhang Junge 100,000 0.4100 100,000 0.4100 41,000
2019-11-18 OCGN Zhang Junge 98,500 0.4100 98,500 0.4100 40,385
2019-10-11 OCGN Zhang Junge 4,000 1.4800 4,000 1.4800 5,920
2019-09-30 OCGN Zhang Junge 197 2.4500 3 147.0000 483
2019-09-30 OCGN Zhang Junge 200 2.4600 3 147.6000 492
2019-09-30 OCGN Zhang Junge 1,358 2.4700 23 148.2000 3,354
2019-09-30 OCGN Zhang Junge 100 2.4500 2 147.0000 245
2019-09-30 OCGN Zhang Junge 3,000 2.4800 50 148.8000 7,440
2019-09-30 OCGN Zhang Junge 660 2.5000 11 150.0000 1,650
2019-09-30 OCGN Zhang Junge 200 2.4900 3 149.4000 498
2019-09-30 OCGN Zhang Junge 200 2.6200 3 157.2000 524
2019-09-30 OCGN Zhang Junge 10,000 3.1000 167 186.0000 31,000
2019-09-30 OCGN Zhang Junge 2,000 3.3500 33 201.0000 6,700
2019-09-30 OCGN Zhang Junge 1,163 3.1000 19 186.0000 3,605
2019-09-30 OCGN Zhang Junge 2,000 3.8000 33 228.0000 7,600
2019-09-30 OCGN Zhang Junge 5,000 3.3500 83 201.0000 16,750
2019-09-30 OCGN Zhang Junge 3,000 3.3000 50 198.0000 9,900
2019-09-30 OCGN Zhang Junge 2,000 2.9500 33 177.0000 5,900

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

OCGN / Ocugen, Inc. Insider Trades
Insider Sales OCGN / Ocugen, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in OCGN / Ocugen, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

OCGN / Ocugen, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Junge Zhang as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2023-06-16 2023-06-14 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 200,278 1,077,182 22.84 0.50 99,999 537,837
2022-03-04 2022-03-03 4 OCGN Ocugen, Inc.
Option (Right to Buy)
M - Exercise 49,000 77,000 175.00
2022-03-04 2022-03-03 4 OCGN Ocugen, Inc.
Option (Right to Buy)
M - Exercise 39,000 15,000 -162.50
2022-03-04 2022-03-03 4 OCGN Ocugen, Inc.
Common Stock
M - Exercise 49,000 88,000 125.64 1.83 89,670 161,040
2022-03-04 2022-03-03 4 OCGN Ocugen, Inc.
Common Stock
M - Exercise 39,000 39,000 0.51 19,890 19,890
2021-12-17 2021-12-16 4 OCGN Ocugen, Inc.
Option (Right to Buy)
A - Award 16,335 16,335
2021-12-17 2021-11-16 4 OCGN Ocugen, Inc.
Warrants (Right to Buy)
X - Other -1,653 0 -100.00
2021-12-17 2021-11-16 4 OCGN Ocugen, Inc.
Warrants (Right to Buy)
X - Other -143,820 0 -100.00
2021-12-17 2021-11-16 4 OCGN Ocugen, Inc.
Common Stock
X - Other 1,653 876,904 0.19 7.56 12,497 6,629,394
2021-12-17 2021-11-16 4 OCGN Ocugen, Inc.
Common Stock
X - Other 143,820 875,251 19.66 2.77 398,381 2,424,445
2021-11-05 2021-11-03 4 OCGN Ocugen, Inc.
Common Stock
S - Sale X -150,300 731,431 -17.05 17.32 -2,603,196 12,668,385
2021-11-03 2021-11-02 4 OCGN Ocugen, Inc.
Common Stock
S - Sale X -149,700 881,731 -14.51 15.75 -2,357,775 13,887,263
2021-01-04 2021-01-01 4 OCGN Ocugen, Inc.
Option (Right to Buy)
A - Award 126,000 126,000
2020-01-03 2020-01-02 4 OCGN Ocugen, Inc.
Options (Right to Buy)
A - Award 54,000 54,000
2019-12-05 2019-12-04 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 220,000 818,578 36.75 0.44 96,800 360,174
2019-12-04 2019-11-18 4/A OCGN Ocugen, Inc.
Common Stock
P - Purchase 98,500 133,578 280.80 0.41 40,385 54,767
2019-12-02 2019-11-27 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 270,000 600,078 81.80 0.37 99,900 222,029
2019-11-26 2019-11-25 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 115,000 330,078 53.47 0.27 31,050 89,121
2019-11-26 2019-11-22 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 80,000 215,078 59.23 0.28 22,400 60,222
2019-11-20 2019-11-18 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 100,000 135,078 285.08 0.41 41,000 55,382
2019-10-15 2019-10-11 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 4,000 35,078 12.87 1.48 5,920 51,915
2019-10-04 3 OCGN Ocugen, Inc.
Common Stock
425,726
2019-10-04 3 OCGN Ocugen, Inc.
Common Stock
425,726
2019-10-04 3 OCGN Ocugen, Inc.
Common Stock
425,726
2019-10-04 2019-09-30 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 2,000 31,078 6.88 2.95 5,900 91,680
2019-10-04 2019-09-30 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 3,000 29,078 11.50 3.30 9,900 95,957
2019-10-04 2019-09-30 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 5,000 26,078 23.72 3.35 16,750 87,361
2019-10-04 2019-09-30 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 2,000 21,078 10.48 3.80 7,600 80,096
2019-10-04 2019-09-30 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 1,163 19,078 6.49 3.10 3,605 59,142
2019-10-04 2019-09-30 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 2,000 17,915 12.57 3.35 6,700 60,015
2019-10-04 2019-09-30 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 10,000 15,915 169.06 3.10 31,000 49,336
2019-10-04 2019-09-30 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 200 5,915 3.50 2.62 524 15,497
2019-10-04 2019-09-30 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 200 5,715 3.63 2.49 498 14,230
2019-10-04 2019-09-30 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 660 5,515 13.59 2.50 1,650 13,788
2019-10-04 2019-09-30 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 3,000 4,855 161.73 2.48 7,440 12,040
2019-10-04 2019-09-30 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 100 1,855 5.70 2.45 245 4,545
2019-10-04 2019-09-30 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 1,358 1,755 342.07 2.47 3,354 4,335
2019-10-04 2019-09-30 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 200 397 101.52 2.46 492 977
2019-10-04 2019-09-30 4 OCGN Ocugen, Inc.
Common Stock
P - Purchase 197 197 2.45 483 483
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)